SE392271B - Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan - Google Patents
Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkanInfo
- Publication number
- SE392271B SE392271B SE7603651A SE7603651A SE392271B SE 392271 B SE392271 B SE 392271B SE 7603651 A SE7603651 A SE 7603651A SE 7603651 A SE7603651 A SE 7603651A SE 392271 B SE392271 B SE 392271B
- Authority
- SE
- Sweden
- Prior art keywords
- derivatives
- trimetoxybenzoyl
- trimethoxybenzoyloxy
- alkyl
- procedure
- Prior art date
Links
- -1 3,4,5-TRIMETHOXYBENZOYLOXY Chemical class 0.000 title 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 title 1
- 150000004050 homopiperazines Chemical class 0.000 title 1
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7603651A SE392271B (sv) | 1976-03-25 | 1976-03-25 | Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7603651A SE392271B (sv) | 1976-03-25 | 1976-03-25 | Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7603651L SE7603651L (sv) | 1976-03-25 |
SE392271B true SE392271B (sv) | 1977-03-21 |
Family
ID=20327393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7603651A SE392271B (sv) | 1976-03-25 | 1976-03-25 | Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan |
Country Status (1)
Country | Link |
---|---|
SE (1) | SE392271B (sv) |
-
1976
- 1976-03-25 SE SE7603651A patent/SE392271B/sv unknown
Also Published As
Publication number | Publication date |
---|---|
SE7603651L (sv) | 1976-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE437022B (sv) | Forfarande for framstellning av n-substituerade morfolinderivat respektive piperidinderivat | |
NO149102C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive trans-4-fenyl-1,2,3,4-tetrahydro-1-naftalenamin-derivater | |
NO147243C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater | |
NO148150C (no) | Analogifremstilling av terapeutisk aktive piperazinderivater | |
NO151411C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater | |
SE431333B (sv) | Analogiforfarande for framstellning av piperazin- och piperidinderivat | |
NO800881L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater | |
NO774126L (no) | Fremgangsmaate for fremstilling av tiazolidin- og tiazanderivater | |
FI773738A (fi) | Foerfarande foer framstaellning av n-(bentstiazol-2-yl)-oxamidsyra-derivat | |
NO800664L (no) | Analogifremgangsmaate for fremstilling av hydroksypyrimidinderivater | |
SE429338B (sv) | Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan | |
NO145951C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolinderivater | |
NO148524C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater av guanidin | |
SE423813B (sv) | Forfarande for framstellning av 1,5-disubstituerade pyrrolidoner med terapeutiska egenskaper | |
SE414633B (sv) | Forfarande for framstellning av nya 4-(3-tert butylamino-propoxi)-2-metyl-indolderivat med terapeutisk verkan | |
SE411671B (sv) | Forfarande for framstellning av tripeptidderivat med terapeutisk verkan | |
SE7804736L (sv) | Forfarande for framstellning av isoindolinderivat med terapeutisk verkan | |
SE7800930L (sv) | Forfarande for framstellning av bensensulfonamid- och bensenkarboxamidderivat med terapeutisk verkan | |
NO146710C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylpiperazinderivater | |
NO794318L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive spiro-kinolyl-hydantoin-derivater | |
FI790320A (fi) | Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan | |
SE392271B (sv) | Forfarande for framstellning av 1(2,3,4-trimetoxibensoyl)-4-(3-(3,4,5-trimetoxibensoyloxi)alkyl)piperazinderivat och -homopiperazinderivat med terapeutisk verkan | |
SE7608115L (sv) | Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan | |
SE7709402L (sv) | Forfarande for framstellning av tetrahydropyridinderivat | |
SE7805105L (sv) | Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan |